氧驱雾化吸入盐酸氨溴索治疗慢阻肺急性加重期患者的临床疗效观察

Clinical observation of oxygen flooding inhalation of ambroxol hydrochloride in patients with acute exacerbation of chronic obstructive pulmonary disease

目的分析氧驱雾化吸入盐酸氨溴索治疗慢阻肺(COPD)急性加重期患者的临床疗效。方法选取2017年6至2018年6月期间崇州市协好医院收治的160例COPD急性加重期患者作为研究对象,并将其分随机为对照组(常规治疗)与观察组(常规治疗+氧驱雾化吸入盐酸氨溴索),两组各80例,对比两组的治疗效果差异。结果观察组的临床疗效优于对照组,差异有统计学意义(P<0.05)。结论采取氧驱雾化吸入盐酸氨溴索治疗COPD急性加重期患者,可明显提高临床疗效,具有积极影响。

Objective To analyze the clinical efficacy of oxygen flooding inhalation of ambroxol hydrochloride in patients with acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods 160 patients with acute exacerbation of COPD admitted to Chongzhou Xiehao Hospital during the period from June 6 to 2018 in 2017 were selected as the study subjects,and they were randomly divided into control group(conventional treatment)and observation group(conventional treatment+oxygen flooding)Inhaled ambroxol hydrochloride,80 patients in each group,the difference in treatment effect between the two groups.Results The clinical efficacy of the observation group was better than that of the control group,and the difference was statistically significant(P<0.05).Conclusion Oxygen flooding inhalation of ambroxol hydrochloride in patients with acute exacerbation of COPD can significantly improve clinical efficacy and has a positive impact.